BioScience Health Innovations annual operating income
2020
2021
2022
2022
2023
2024
2025
BioScience Health Innovations Operating Income Growth & History (BHIC)
BioScience Health Innovations's operating income was $719,051 for fiscal 2025.
View full BioScience Health Innovations company overviewBioScience Health Innovations annual operating income history
| Fiscal year | Period ended | Operating income | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $719,051 | $632,051 | +726.50% |
| 2024 | 2024-12-31 | $87,000 | $338,500 | — |
| 2023 | 2023-12-31 | −$251,500 | −$81,050 | — |
| 2022 · Dec 31 | 2022-12-31 | −$170,450 | — | — |
| 2022 · Aug 31 | 2022-08-31 | −$91,921 | −$66,311 | — |
| 2021 | 2021-08-31 | −$25,610 | −$17,928 | — |
| 2020 | 2020-08-31 | −$7,682 | — | — |
BioScience Health Innovations quarterly operating income
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q2.22
Q3.22
Q3.22
Q3.22
Q1.23
Q1.23
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating income | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$217,882 | −$675,586 | — |
| Q1 2026 | 2026-03-31 | −$229,907 | −$656,705 | — |
| Q4 2025 | 2025-12-31 | −$156,669 | −$166,626 | — |
| Q3 2025 | 2025-09-30 | −$8,782 | −$64,984 | — |
| Q2 2025 | 2025-06-30 | $457,704 | $383,482 | +516.67% |
| Q1 2025 | 2025-03-31 | $426,798 | $480,179 | — |
| Q4 2024 | 2024-12-31 | $9,957 | $48,333 | — |
| Q3 2024 | 2024-09-30 | $56,202 | $113,348 | — |
| Q2 2024 | 2024-06-30 | $74,222 | $159,484 | — |
| Q1 2024 | 2024-03-31 | −$53,381 | $17,335 | — |
| Q4 2023 | 2023-12-31 | −$38,376 | — | — |
| Q3 2023 | 2023-09-30 | −$57,146 | $27,557 | — |
| Q2 2023 | 2023-06-30 | −$85,262 | −$83,384 | — |
| Q1 2023 · Mar 31 | 2023-03-31 | −$70,716 | −$66,505 | — |
| Q1 2023 · Feb 28 | 2023-02-28 | −$20,011 | $6,229 | — |
| Q1 2023 · Nov 30 | 2022-11-30 | −$28,917 | −$14,828 | — |
| Q3 2022 · Sep 30 | 2022-09-30 | −$84,703 | — | — |
| Q3 2022 · Jun 30 | 2022-06-30 | −$1,878 | — | — |
| Q3 2022 · May 31 | 2022-05-31 | −$47,884 | −$44,675 | — |
| Q2 2022 · Mar 31 | 2022-03-31 | −$4,211 | — | — |
| Q2 2022 · Feb 28 | 2022-02-28 | −$26,240 | −$13,572 | — |
| Q1 2022 | 2021-11-30 | −$14,089 | −$8,511 | — |
| Q4 2021 | 2021-08-31 | −$4,155 | −$1,260 | — |
| Q3 2021 | 2021-05-31 | −$3,209 | −$348 | — |
| Q2 2021 | 2021-02-28 | −$12,668 | −$10,742 | — |
| Q1 2021 | 2020-11-30 | −$5,578 | −$5,578 | — |
| Q4 2020 | 2020-08-31 | −$2,895 | — | — |
| Q3 2020 | 2020-05-31 | −$2,861 | — | — |
| Q2 2020 | 2020-02-29 | −$1,926 | — | — |
| Q1 2020 | 2019-11-30 | $0 | — | — |
BioScience Health Innovations operating income trends
Between the periods ended 2020-08-31 and 2025-12-31, BioScience Health Innovations's operating income increased from −$7,682 to $719,051, a change of $726,733. The latest reported quarter, Q2 2026, shows −$217,882.
About the metric
What operating income means
Operating income is the profit or loss a company generates from its core business after cost of revenue and operating expenses, but before non-operating items such as interest and income taxes.
Calculation and source
SEC-reported operating income
TickerStat standardizes operating income reported in company SEC filings for aligned fiscal periods. It is not adjusted EBIT, an analyst estimate, or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review BioScience Health Innovations source filings ↗